Enteroaggregative Escherichia coli (EAEC) is a major cause of diarrhoeal disease in industrialised and non-industrialised countries and is the cause of travellers’ diarrhoea and persistent diarrhoea in children and HIV patients. EAEC strains cause disease by binding to the human gastric mucosa and establishing a thick mucoid biofilm, damaging tissue by secreting various toxins [1]. In spite of their widespread occurrence and impact on human health, little is known about how EAEC strains control the expression of genes required to establish infection and cause disease. Furthermore, EAEC strains are increasingly resistant to many clinical antibiotics, decreasing treatment options [1-4]. Thus, there is a need to understand EAEC pathology and devise new methods to combat this important group of bacterial pathogens.
In many EAEC strains, the expression of important virulence determinants (e.g., the attachment adherence fimbriae (AAF) required for colonization, the anti-aggregative protein dispersin (Aap) and its dedicated secretion system) is controlled by the AggR transcription factor, the master regulator of virulence [1-3]. Recently, we have been working with EAEC strains isolated from Egyptian and Brazilian children with diarrhoea [3,4]. In these strains, we have found a new version of AggR that controls gene expression differently. Thus, the main aim of this project will be to determine how this version of AggR controls virulence and determine the genes that it regulates. We have already had the genomes of many of these strains fully sequenced, and so part of this project will be to analyse their genomes to determine each strains characteristics (e.g., antibiotic resistance gene profile, virulence determinants and plasmid replicons etc.). The project will also use synthetic biology to engineer and deliver mutant versions of AggR into EAEC cells, blocking specific promoters and virulence gene expression, as a potential therapeutic approach to combating EAEC infection.
References: *Research from the host's laboratory
- Harrington, S.M., Dudley, E.G. and Nataro, J.P. (2006.) Pathogenesis of enteroaggregative Escherichia coli infection. FEMS Microbiol Lett. 254(1):12-8. Review.
- Yasir, M., Icke, C., Abdelwahab, R., Haycocks, J.R., Godfrey, R.E., Sazinas, P., Pallen, M.J., Henderson, I.R., Busby S.J.W. and Browning, D.F. (2019) Organization and architecture of AggR-dependent promoters from Enteroaggregative Escherichia coli. Molecular Microbiology. 111:534-551.
- Abdelwahab, R., Yasir, M., Godfrey, R.E., Christie, G.S., Element, S.J., Saville, F., Hassan, E.A., Ahmed, E.H., Abu-Faddan, N.H., Daef, E.A., Busby, S.J.W. and Browning, D.F. (2021) Antimicrobial resistance and gene regulation in Enteroaggregative Escherichia coli from Egyptian children with diarrhoea: similarities and differences. Virulence 12:57-74
- França, F.L.S., Wells, T.J, Browning, D.F., Nogueira, R.T., Sarges, F.S., Pereira, A. C., Cunningham, A.F., Lucheze, K., Rosa, A.C.P., Henderson, I.R. and das Graças de Luna, M. (2013) Genotypic and phenotypic characterisation of enteroaggregative Escherichia coli from children in Rio de Janeiro, Brazil. PLOS ONE 10.1371/journal.pone.0069971.